Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial)
Titel:
Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial)
Auteur:
Hendriks, Pim Rietbergen, Daphne D. D. van Erkel, Arian R. Coenraad, Minneke J. Arntz, Mark J. Bennink, Roel J. Braat, Andries E. Crobach, Stijn van Delden, Otto M. Dibbets-Schneider, Petra van der Hulle, Tom Klümpen, Heinz-Josef van der Meer, Rutger W. Nijsen, J. Frank W. van Rijswijk, Catharina S. P. Roosen, Joey Ruijter, Bastian N. Smit, Frits Stam, Mette K. Takkenberg, R. Bart Tushuizen, Maarten E. van Velden, Floris H. P. de Geus-Oei, Lioe-Fee Burgmans, Mark C. ,
Verschenen in:
European journal of nuclear medicine and molecular imaging